DK1074542T3 - Sulfonamidholdige indolforbindelser - Google Patents
Sulfonamidholdige indolforbindelserInfo
- Publication number
- DK1074542T3 DK1074542T3 DK00905321T DK00905321T DK1074542T3 DK 1074542 T3 DK1074542 T3 DK 1074542T3 DK 00905321 T DK00905321 T DK 00905321T DK 00905321 T DK00905321 T DK 00905321T DK 1074542 T3 DK1074542 T3 DK 1074542T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrogen
- ring
- represents hydrogen
- indole compounds
- cyanophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11049870A JP2000247949A (ja) | 1999-02-26 | 1999-02-26 | スルホンアミド含有インドール化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1074542T3 true DK1074542T3 (da) | 2006-08-14 |
Family
ID=12843091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00905321T DK1074542T3 (da) | 1999-02-26 | 2000-02-24 | Sulfonamidholdige indolforbindelser |
Country Status (17)
Country | Link |
---|---|
US (3) | US6469043B1 (fr) |
EP (1) | EP1074542B1 (fr) |
JP (3) | JP2000247949A (fr) |
KR (1) | KR100627611B1 (fr) |
CN (1) | CN1132814C (fr) |
AT (1) | ATE325094T1 (fr) |
AU (1) | AU766936B2 (fr) |
CA (1) | CA2327253C (fr) |
DE (1) | DE60027648T2 (fr) |
DK (1) | DK1074542T3 (fr) |
ES (1) | ES2259997T3 (fr) |
HU (1) | HU228787B1 (fr) |
NO (1) | NO317299B1 (fr) |
NZ (1) | NZ507464A (fr) |
PT (1) | PT1074542E (fr) |
RU (1) | RU2208607C2 (fr) |
WO (1) | WO2000050395A1 (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4039856B2 (ja) * | 2000-02-03 | 2008-01-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | インテグリン発現阻害剤 |
EP1317260A2 (fr) * | 2000-08-30 | 2003-06-11 | Signature Bioscience, Inc. | Procedes de therapie antitumorale |
TWI283575B (en) * | 2000-10-31 | 2007-07-11 | Eisai Co Ltd | Medicinal compositions for concomitant use as anticancer agent |
AU2002233677B2 (en) * | 2001-02-21 | 2005-01-06 | Eisai R&D Management Co., Ltd. | Method of examining effect of angiogenesis inhibitor mediated by the inhibition of integrin expression |
EP1430894A4 (fr) * | 2001-09-05 | 2007-12-12 | Eisai R&D Man Co Ltd | Inhibiteur d'activation lymphocytaire et remede pour maladie auto-immune |
WO2003022272A1 (fr) * | 2001-09-05 | 2003-03-20 | Eisai C0. Ltd. | Agents stimulant l'appetit et remedes contre l'anorexie |
EP1481678A4 (fr) * | 2002-03-05 | 2009-12-30 | Eisai R&D Man Co Ltd | Agent antitumoral comprenant une combinaison d'un compose heterocyclique contenant un sulfamide et d'un inhibiteur d'angiogenese |
EP1608626A1 (fr) | 2003-03-28 | 2005-12-28 | Cornell Research Foundation, Inc. | Compositions de substances analogues a la migrastatine et leurs utilisations |
WO2004091664A1 (fr) * | 2003-04-18 | 2004-10-28 | Eisai Co., Ltd. | Inhibiteur de malate dehydogenase cytoplasmique |
DE602004029907D1 (de) * | 2003-09-10 | 2010-12-16 | Eisai R&D Man Co Ltd | Kristall einer sulfonamidhaltigen indolverbindung und verfahren zu dessen herstellung |
JP4418430B2 (ja) * | 2003-09-10 | 2010-02-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド含有インドール化合物の製造方法 |
ES2382942T3 (es) * | 2003-11-13 | 2012-06-14 | Sutter West Bay Hospitals | Terapia anti-pecam para la supresión de la metástasis |
WO2006001967A2 (fr) * | 2004-05-25 | 2006-01-05 | Sloan-Kettering Institute For Cancer Research | Analogues de migrastatine utilises dans le traitement du cancer |
US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
EP2364699A1 (fr) | 2004-09-13 | 2011-09-14 | Eisai R&D Management Co., Ltd. | Utilisation conjointe d'un composé à base de sulfonamide avec un inhibiteur de l'angiogénèse |
US8188141B2 (en) * | 2004-09-23 | 2012-05-29 | Sloan-Kettering Institute For Cancer Research | Isomigrastatin analogs in the treatment of cancer |
DK1859793T3 (da) | 2005-02-28 | 2011-08-01 | Eisai R&D Man Co Ltd | Hidtil ukendt kombinationsanvendelse af en sulfonamidforbindelse i behandlingen af cancer |
JP5094394B2 (ja) * | 2005-04-20 | 2012-12-12 | 武田薬品工業株式会社 | 縮合複素環化合物 |
RU2448703C2 (ru) * | 2005-11-23 | 2012-04-27 | Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем | Онкогенное ras-специфичное цитотоксическое соединение и способы его применения |
US7625896B2 (en) * | 2005-11-25 | 2009-12-01 | Hoffman-La Roche Inc. | Pyridylsulfonamide derivatives |
WO2007086605A1 (fr) * | 2006-01-27 | 2007-08-02 | Eisai R & D Management Co., Ltd. | Procédé de prédiction de l'effet d'un composé de sulfonamide |
WO2007123274A1 (fr) | 2006-04-20 | 2007-11-01 | Eisai R & D Management Co., Ltd. | Nouveau marqueur CONTRE la SENSIBILITÉ À un COMPOSÉ de sulfonamide |
DE102007012284A1 (de) * | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007035333A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007035334A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
DE102007042154A1 (de) | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
US20090142832A1 (en) * | 2007-11-29 | 2009-06-04 | James Dalton | Indoles, Derivatives, and Analogs Thereof and Uses Therefor |
JP2012136435A (ja) * | 2009-03-30 | 2012-07-19 | Eisai R & D Management Co Ltd | 腫瘍組織の感受性を検査する方法 |
BR112014020773A2 (pt) | 2012-02-22 | 2020-10-27 | Sanford-Burnham Medical Research Institute | compostos de sulfonamida e seus usos como inibidores tnap |
CN104098498A (zh) * | 2014-07-30 | 2014-10-15 | 天津市斯芬克司药物研发有限公司 | 一种吲唑类化合物及其制备方法 |
EP3717481B1 (fr) * | 2017-11-27 | 2023-03-01 | Council of Scientific & Industrial Research | Dérivés d'indole (sulfomyl) n-hydroxy benzamide en tant qu'inhibiteurs sélectifs de hdac |
JP2021511290A (ja) * | 2018-01-25 | 2021-05-06 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | タンパク質分解のためのスルホンアミド誘導体 |
US20220162193A1 (en) * | 2019-04-10 | 2022-05-26 | Peloton Therapeutics, Inc. | Pyrazolesulfonamides as antitumor agents |
WO2024039689A1 (fr) * | 2022-08-15 | 2024-02-22 | Recursion Pharmaceuticals, Inc. | Modulateurs de rbm39 hétérocycliques |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9115160D0 (en) * | 1991-07-12 | 1991-08-28 | Erba Carlo Spa | Methylen-oxindole derivatives and process for their preparation |
RU2128648C1 (ru) | 1993-09-10 | 1999-04-10 | Эйсай Ко. Лтд. | Производные сульфонамида, способы их получения, фармацевтическая композиция и способ лечения |
JP3545461B2 (ja) * | 1993-09-10 | 2004-07-21 | エーザイ株式会社 | 二環式ヘテロ環含有スルホンアミド誘導体 |
JP3690831B2 (ja) * | 1995-02-27 | 2005-08-31 | エーザイ株式会社 | インドール含有スルホンアミド誘導体 |
JP4130700B2 (ja) | 1996-02-26 | 2008-08-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗腫瘍剤含有組成物 |
JP3868534B2 (ja) | 1996-05-24 | 2007-01-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド誘導体の製造法および中間体 |
JP4039856B2 (ja) * | 2000-02-03 | 2008-01-30 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | インテグリン発現阻害剤 |
-
1999
- 1999-02-26 JP JP11049870A patent/JP2000247949A/ja active Pending
-
2000
- 2000-02-24 AT AT00905321T patent/ATE325094T1/de active
- 2000-02-24 JP JP2000600978A patent/JP3866041B2/ja not_active Expired - Fee Related
- 2000-02-24 US US09/647,215 patent/US6469043B1/en not_active Expired - Lifetime
- 2000-02-24 DK DK00905321T patent/DK1074542T3/da active
- 2000-02-24 NZ NZ507464A patent/NZ507464A/en not_active IP Right Cessation
- 2000-02-24 PT PT00905321T patent/PT1074542E/pt unknown
- 2000-02-24 ES ES00905321T patent/ES2259997T3/es not_active Expired - Lifetime
- 2000-02-24 HU HU0101434A patent/HU228787B1/hu not_active IP Right Cessation
- 2000-02-24 DE DE60027648T patent/DE60027648T2/de not_active Expired - Lifetime
- 2000-02-24 RU RU2000129508/04A patent/RU2208607C2/ru not_active IP Right Cessation
- 2000-02-24 EP EP00905321A patent/EP1074542B1/fr not_active Expired - Lifetime
- 2000-02-24 CA CA002327253A patent/CA2327253C/fr not_active Expired - Fee Related
- 2000-02-24 KR KR1020007011026A patent/KR100627611B1/ko not_active IP Right Cessation
- 2000-02-24 AU AU26916/00A patent/AU766936B2/en not_active Ceased
- 2000-02-24 WO PCT/JP2000/001071 patent/WO2000050395A1/fr active IP Right Grant
- 2000-02-24 CN CN008002290A patent/CN1132814C/zh not_active Expired - Fee Related
- 2000-10-24 NO NO20005357A patent/NO317299B1/no not_active IP Right Cessation
-
2002
- 2002-03-18 US US10/098,421 patent/US6638964B2/en not_active Expired - Lifetime
- 2002-03-18 US US10/098,420 patent/US6673787B2/en not_active Expired - Lifetime
-
2010
- 2010-04-02 JP JP2010085696A patent/JP2010180229A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU766936B2 (en) | 2003-10-23 |
CN1294579A (zh) | 2001-05-09 |
DE60027648D1 (de) | 2006-06-08 |
KR100627611B1 (ko) | 2006-09-25 |
US6673787B2 (en) | 2004-01-06 |
ATE325094T1 (de) | 2006-06-15 |
HUP0101434A3 (en) | 2001-10-29 |
PT1074542E (pt) | 2006-07-31 |
NZ507464A (en) | 2003-10-31 |
HUP0101434A2 (hu) | 2001-09-28 |
EP1074542A1 (fr) | 2001-02-07 |
US6469043B1 (en) | 2002-10-22 |
NO20005357L (no) | 2000-12-22 |
NO317299B1 (no) | 2004-10-04 |
KR20010042434A (ko) | 2001-05-25 |
JP2010180229A (ja) | 2010-08-19 |
US20020128480A1 (en) | 2002-09-12 |
CA2327253A1 (fr) | 2000-08-31 |
CN1132814C (zh) | 2003-12-31 |
WO2000050395A1 (fr) | 2000-08-31 |
JP3866041B2 (ja) | 2007-01-10 |
CA2327253C (fr) | 2007-10-16 |
US20020128483A1 (en) | 2002-09-12 |
AU2691600A (en) | 2000-09-14 |
JP2000247949A (ja) | 2000-09-12 |
US6638964B2 (en) | 2003-10-28 |
EP1074542B1 (fr) | 2006-05-03 |
EP1074542A4 (fr) | 2002-02-06 |
RU2208607C2 (ru) | 2003-07-20 |
DE60027648T2 (de) | 2007-04-05 |
HU228787B1 (en) | 2013-05-28 |
NO20005357D0 (no) | 2000-10-24 |
ES2259997T3 (es) | 2006-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1074542T3 (da) | Sulfonamidholdige indolforbindelser | |
NZ514873A (en) | 4,5,6,7-tetrahydroindazole derivatives as antitumor agents | |
ATE129714T1 (de) | Heterocyclische biphosphonsäurederivate. | |
NZ336302A (en) | Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia | |
DK0749424T3 (da) | Naphthalenderivater som prostaglandin-I2-agonister | |
DK0928788T3 (da) | Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler | |
DE69609325D1 (de) | Derivate des radicicols | |
NO934536L (no) | Fenoksy- og fenoksyalkyl-pepiridiner som antivirale midler | |
ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
CA2134077A1 (fr) | 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines servant de 5ht2-antagonistes de la serotonine, leur mode d'obtention et leur usage therapeutique | |
ATE233242T1 (de) | Chinoline und chinazoline verbindungen und ihre therapeutische anwendung | |
NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
NO961797L (no) | Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter | |
TR200002831A2 (tr) | Kinolin-4-İl türevleri I | |
MEP12408A (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors | |
HUP9902270A1 (hu) | Analgetikus hatású akridinszármazékok, előállításuk és alkalmazásuk | |
HUP0002715A2 (hu) | Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására | |
EP0254527A3 (en) | New tetracyclic indole derivatives | |
ES2182775T3 (es) | Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion. | |
ECSP993005A (es) | Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos |